165
Participants
Start Date
October 1, 2019
Primary Completion Date
October 1, 2024
Study Completion Date
December 31, 2024
Losartan
This trial is open-label; therefore, the participant, the trial site personnel, the Sponsor and/or designee are not blinded to treatment. Drug identity (name, strength) is included in the label text. Storage, handling and preparation requirements will be handled in concordance with the Pharmacy Manual for losartan.
Oslo University Hospital, Oslo
Kyrre Eeg Emblem
OTHER